IL2 and myeloid sarcoma: However, there is a minor, yet detectable population in CD4+CD25high+CD127+ cells, these T-cells showed higher proliferative capacity and produced more IFNγ and IL-2 as compared to cells from healthy control individuals [17] suggesting an abnormal function of CD4+CD25high, CD127+ T-cells in patients with MS.